Blood Platelet Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
A look at the recent research trends in the global blood platelet market reveals the identification of mechanisms behind the key cause of mortality and morbidity in COVID-19 patients by a team of Yale University researchers. A wide range of blood clots in both small and large blood vessels in the lungs and throughout numerous major organs in the body have connections, in turn worsening the outcomes for patients severely infected with COVID-19.
Platelets are the first defense against vascular damage in the human body. However, a lately published study in the journal “Blood” has demonstrated the triggering of platelet dysfunction and damage by the SARS-CoV-2 virus. Additional injury to the endothelial cells, the cells which line lymphatic vessels and blood, may further appear to be connected to severe illness and death, in turn contributing to worsening outcomes in COVID-19 patients, creating the need for maintaining blood platelet count among such patients.
Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/2849
Similar studies are expected to drive product adoption by increasing the demand for medication to increase platelets over the coming years. According to the latest research by GMI, Inc., the global blood platelet market size is estimated to surpass USD 5.1 billion by 2026.
This growth is primarily attributed to the surging prevalence of blood-related and chronic disorders demanding a greater number of blood donations. Further, an escalation in the geriatric population that is likely to suffer from liver, blood-related, and immune system disorders is expected to push blood platelet market expansion over the estimated period.
Some major trends impelling blood platelet industry outlook comprise:
Rising prevalence of thrombocytopenia to escalate revenue growth
The increasing prevalence of thrombocytopenia symptoms at the global level is one of the prominent factors influencing blood platelet market size through the forthcoming years. Thrombocytopenia represents the most common disorder in patients, in turn leading to the depletion of blood platelet count.
The increasing number of patients with a continuous and urgent requirement for maintaining the normal platelet count is expected to drive the requirement for transfusions and advanced therapies, in turn stimulating blood platelet industry growth over the assessment span.
Large inflow of patients with severe surgeries to augment hospital segment share
A rise in the number of new hospitals having advanced facilities has been instrumental in causing a surge in the demand for blood platelets. The hospital segment is anticipated to expand at a CAGR of more than 3.0 per cent through the projected span. This growth is ascribed to the higher availability of blood components comprising plasma and platelets in hospitals.
Further, an increase in the inflow of patients requiring severe surgeries in hospitals is expected to escalate the demand for blood platelets owing to the surging requirement for performing blood transfusion procedures.
Brazil to contribute a commendable revenue to the soaring Latin America blood platelet market
Rising awareness regarding the increasing requirement for blood platelets in the human body is expected to drive Latin America blood platelet market outlook through the forthcoming years. The blood platelet market in Brazil had a valuation of more than USD 93 million in 2019.
A surge in the awareness initiatives conducted by the Brazilian Red Cross has been instrumental in boosting blood donations in the country, in turn propelling blood platelet demand and supply. ANVISA, the Brazilian Health Authorities, is also focused on regulating blood donations in Brazil, in turn influencing the industry landscape through the estimated period.
In a nutshell, the increasing involvement of market players in conducting numerous blood donation campaigns is expected to drive blood platelets market demand through the forthcoming years. Prominent players in the blood platelets industry comprise the American National Red Cross, Brazilian Red Cross, European Blood Alliance (EBA), American Association of Blood Banks (AABB), Canadian Blood Services, OneBlood, and others.
Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/blood-platelet-market
Partial Chapter of the Table of Content
Chapter 2 Executive Summary
2.1 Blood platelets industry 3600 synopsis, 2015 - 2026
2.1.1 Business trends
2.1.2 Application trends
2.1.3 End-use trends
2.1.4 Regional trends
Chapter 3 Blood Platelets Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2015 – 2026
3.3 Industry impact forces
3.3.1 Growth drivers
22.214.171.124 Increasing prevalence of chronic and blood-related disorders
126.96.36.199 Growing demand for blood transfusions
188.8.131.52 Rise in awareness regarding blood donations and platelets transfusions
184.108.40.206 Favourable reimbursement policies in developed countries
3.3.2 Industry pitfalls & challenges
220.127.116.11 High risk of transmissions of infections
18.104.22.168 High cost of the treatment
3.4 Growth potential analysis
3.4.1 By application
3.4.2 By end-use
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2019
3.7.1 Company matrix analysis
3.8 PESTEL analysis